These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19373011)

  • 1. Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings.
    Cheng B; Landay A; Miller V
    Curr Opin HIV AIDS; 2008 Jul; 3(4):495-503. PubMed ID: 19373011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.
    O'Gorman MR; Zijenah LS
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S19-26. PubMed ID: 18228562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of HIV: implications for resource-limited settings.
    Hobbs CV; Essajee SM
    Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in implementing CD4 testing in resource-limited settings.
    Peter T; Badrichani A; Wu E; Freeman R; Ncube B; Ariki F; Daily J; Shimada Y; Murtagh M
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S123-30. PubMed ID: 18348208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences.
    Creek TL; Sherman GG; Nkengasong J; Lu L; Finkbeiner T; Fowler MG; Rivadeneira E; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S64-71. PubMed ID: 17825652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient needs and point-of-care requirements for HIV load testing in resource-limited settings.
    Usdin M; Guillerm M; Calmy A
    J Infect Dis; 2010 Apr; 201 Suppl 1():S73-7. PubMed ID: 20225951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research for change: using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings.
    Hirschhorn LR; Ojikutu B; Rodriguez W
    J Infect Dis; 2007 Dec; 196 Suppl 3():S516-22. PubMed ID: 18181704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The United States Department of Energy's Regional Carbon Sequestration Partnerships Program Validation Phase.
    Litynski JT; Plasynski S; McIlvried HG; Mahoney C; Srivastava RD
    Environ Int; 2008 Jan; 34(1):127-38. PubMed ID: 17950875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antiretroviral therapy mortality in resource-limited settings: what can we do about it?
    Bekker LG; Egger M; Wood R
    Curr Opin HIV AIDS; 2007 Jul; 2(4):346-51. PubMed ID: 19372910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstitution disease: recent developments and implications for antiretroviral treatment in resource-limited settings.
    Lawn SD; French MA
    Curr Opin HIV AIDS; 2007 Jul; 2(4):339-45. PubMed ID: 19372909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitor therapy in resource-limited settings.
    Elliott JH; Pujari S
    Curr Opin HIV AIDS; 2008 Nov; 3(6):612-9. PubMed ID: 19373032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified cytometry for routine monitoring of infectious diseases.
    Janossy G; Shapiro H
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S6-10. PubMed ID: 18228555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostics in the shadow of HIV epidemics.
    Janossy G; Mandy F; O'Gorman MR
    Cytometry B Clin Cytom; 2008; 74 Suppl 1():S1-3. PubMed ID: 18338401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicides for the prevention of HIV infection in women: an overview of recent trials.
    Rosenberg ZF; Nel A; Heyward W; Mitchnick M
    Curr Opin HIV AIDS; 2006 Nov; 1(6):514-9. PubMed ID: 19372855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring HIV treatment in resource-limited settings: reassuring news on the usefulness of CD4(+) cell counts.
    Fowler MG; Owor M
    J Infect Dis; 2009 May; 199(9):1255-7. PubMed ID: 19317627
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapy during infancy: essential intervention for resource-limited settings.
    Eley BS
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):585-9. PubMed ID: 18847398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HIV research in building health system capacity in developing countries.
    Zewdie D; Cahn P; McClure C; Bataringaya J
    Curr Opin HIV AIDS; 2008 Jul; 3(4):481-8. PubMed ID: 19373009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.